Prof K Nageshwar: Jagan Acts On Uddhanam Nephropathy [HD] (Video)

         Uddanam Nephropathy is a chronic kidney disease in Srikakulam district, which has affected people in the mandals of Kaviti, Sompeta, Kanchili, Itchapuram, Palasa and Vajrapukotturu over the last two decades, with no cure in sight.

Thousands of people in the region have been affected by the disease, with both young and old, succumbing to the mysterious condition.

The World Health Organization has also listed Uddanam as one of the three regions in the world with the highest concentration of chronic kidney disease, after Sri Lanka and Nicaragua.
https://www.thenewsminute.com/article/uddanam-nephropathy-ap-govt-sanctions-super-speciality-hospital-research-centre-108319

Facebook Comments

About Gopi

Gopi Adusumilli is a Programmer. He is the editor of SocialNews.XYZ and President of AGK Fire Inc.

He enjoys designing websites, developing mobile applications and publishing news articles on current events from various authenticated news sources.

When it comes to writing he likes to write about current world politics and Indian Movies. His future plans include developing SocialNews.XYZ into a News website that has no bias or judgment towards any.

He can be reached at gopi@socialnews.xyz

Summary
Title
Prof K Nageshwar: Jagan Acts On Uddhanam Nephropathy [HD] (Video)
Description

Uddanam Nephropathy is a chronic kidney disease in Srikakulam district, which has affected people in the mandals of Kaviti, Sompeta, Kanchili, Itchapuram, Palasa and Vajrapukotturu over the last two decades, with no cure in sight. Thousands of people in the region have been affected by the disease, with both young and old, succumbing to the mysterious condition. The World Health Organization has also listed Uddanam as one of the three regions in the world with the highest concentration of chronic kidney disease, after Sri Lanka and Nicaragua. https://www.thenewsminute.com/article/uddanam-nephropathy-ap-govt-sanctions-super-speciality-hospital-research-centre-108319

Share
More

This website uses cookies.